AxoGen (AXGN)
(Delayed Data from NSDQ)
$16.73 USD
+0.36 (2.20%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $16.74 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, AxoGen, Inc. has a market cap of $753.23M, which represents its share price of $16.37 multiplied by its outstanding shares number of 46.01M. As a small-cap company, AXGN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AXGN 16.73 +0.36(2.20%)
Will AXGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AXGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AXGN
Are Medical Stocks Lagging AxoGen (AXGN) This Year?
Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?
AXGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates
Other News for AXGN
NR7 appears for AXGN after 0.24% move
Is AXGN building bullish momentum? Jack-in-the-box Bullish shows up after dropping 2.32%
Is AXGN likely to continue higher? Reversal New Highs Setup shows up after climbing 4.54%
Is AXGN preparing for a move? Bollinger Band Squeeze shows up after sliding 2.13%
Stochastic Reached Overbought appears for AXGN after 2.37% move